logo-loader
LON:IMM

ImmuPharma PLC

Receive alerts
Market:
LON
Market Cap:
£16.19 m
Price
£0.10
Change
-0.41%
52 weeks high
21.50
52 weeks low
8.50

Viewing results 1-2 of 2

Health

ImmuPharma targets regulatory approval as follow-up study confirms “outstanding” safety profile of Lupuzor

The drug developer also recently raised £2.66mln from its institutional investor, Lanstead Capital, to help execute its corporate strategy...

on 12/8/19
Health

ImmuPharma continues to build data package for flagship lupus treatment

Results from a 62-patient follow-up study are due shortly, while data from a 500-person-strong managed access programme should be available by the end of next year...

on 25/2/19